v3.25.1
EQUITY BASED COMPENSATION
3 Months Ended
Mar. 31, 2025
EQUITY BASED COMPENSATION  
EQUITY BASED COMPENSATION

NOTE 9 – EQUITY BASED COMPENSATION

The Company maintains certain stock-based compensation plans that were approved by the Company’s shareholders and are administered by the Compensation Committee of the Company’s Board of Directors. The stock-based compensation plans provide for the granting of stock options, time and performance based restricted stock units (RSU’s), among other awards to employees, non-employee directors, consultants, and service providers. As of March 31, 2025, the Company had available 4,694,636 shares remaining for future awards under its Omnibus Incentive Plans.

Compensation Expense – The Company recognized the following compensation costs, net of actual forfeitures, related to restricted stock units (“RSUs”) and stock options:

Three Months Ended

March 31, 

    

2025

    

2024

Sales, general, and administrative

$

24

$

140

Research and development

 

2

 

41

Total equity based compensation

$

26

$

181

Restricted Stock Units – We typically grant RSUs to employees and non-employee directors. The following table summarizes the changes in unvested RSUs from January 1, 2025 through March 31, 2025.

Unvested RSUs

Weighted

Average

Number of

Grant-date

    

Shares

    

Fair Value

$ per share

Unvested at January 1, 2025

 

$

Granted

 

159,583

2.01

Unvested at March 31, 2025

159,583

$

2.01

As of March 31, 2025, unrecognized compensation expense for RSUs amounted to $314 which is expected to be recognized over a weighted average period of approximately 2.8 years.

Stock Options – Our outstanding stock options were valued using the Black-Scholes option-pricing model on the date of the award. A summary of the status of stock options activity since January 1, 2025 and at March 31, 2025 is as follows:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Options

    

Price

    

Term

    

Value

$ per share

Outstanding at January 1, 2025

 

$

 

  

 

 

$

Granted

 

478,777

2.01

 

  

 

 

  

Outstanding at March 31, 2025

 

478,777

$

2.01

 

10.0

years

 

$

Exercisable at March 31, 2025

 

$

 

years

 

$

The intrinsic value of a stock option is the amount by which the current market value or the market value upon exercise of the underlying stock exceeds the exercise price of the option.

As of March 31, 2025, unrecognized compensation expense for stock options amounted to $820 which is expected to be recognized over a weighted average period of approximately 2.8 years.

The weighted average of fair value assumptions used in the Black-Scholes option-pricing model for such grants were as follows:

    

2025

Grant date fair value

$1.75

Risk-free interest rate (1)

 

4.07

%

Expected dividend yield (2)

 

%

Expected volatility (3)

 

114.32

%

Expected term of stock options (4)

 

6.44

years

(1) The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.

(2) The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.

(3) The expected volatility is based on historical volatility of the Company’s stock.

(4) The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.